Welcome to our dedicated page for Pennant Group SEC filings (Ticker: PNTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Pennant Group, Inc. filings document the public reporting of a healthcare services holding company with operating subsidiaries in home health, hospice, home care and senior living. Recent Form 8-K reports furnish quarterly and annual results, Regulation FD investor materials, material agreements and amendments tied to acquisitions and financing arrangements.
Proxy filings cover governance, board matters, executive compensation and shareholder voting items. Other material-event amendments provide acquisition-related financial statements and pro forma information, while credit agreement disclosures describe term loans, leverage and coverage covenants, restrictions on indebtedness, liens, dispositions and restricted payments, and healthcare-law-related default provisions.
Morris Gregory K Sr. reported acquisition or exercise transactions in this Form 4 filing.
Pennant Group, Inc. director Morris Gregory K Sr. received an award of 1,900 shares of common stock as a compensation grant. The grant was at no cash cost per share and increased his directly held position to 35,400 shares. According to the disclosure, these awarded shares will vest in three equal annual installments beginning on April 15, 2027.
COVEY STEPHEN M R reported acquisition or exercise transactions in this Form 4 filing.
Pennant Group, Inc. director Stephen M. R. Covey reported receiving a grant of 1,900 shares of Common Stock on April 15, 2026. The award was granted at no cash purchase price and increases his directly held position to 42,150 shares of Common Stock.
These granted shares vest in three equal annual installments beginning on April 15, 2027, meaning the award is tied to continued service over time rather than being fully available immediately.
SMITH BARRY M reported acquisition or exercise transactions in this Form 4 filing.
Pennant Group, Inc. director Barry M. Smith reported receiving a grant of 1,900 shares of common stock on April 15, 2026 as equity compensation. The award was granted at $0.00 per share and increases his directly held position to 100,599 shares after the transaction.
The granted shares vest in three annual installments beginning April 15, 2027, meaning Smith will earn the stock over time if service conditions are met. This filing reflects a routine director equity award rather than an open-market purchase or sale.
Pennant Group, Inc. reported that EVP, General Counsel and Corporate Secretary Kirk Sterling Cheney received equity awards and corrected prior ownership data. On March 3, 2026, he acquired 2,874 shares of common stock as a grant that vests immediately on that date, bringing his direct common stock holdings to 19,794 shares. On March 5, 2026, he was granted a stock option covering 30,000 shares of common stock at an exercise price of $33.30 per share, vesting in five equal annual installments beginning March 5, 2027 and expiring March 5, 2036. The amendment states it is being filed to correct the amount of securities beneficially owned as of the earlier transaction date.
Snapper Suzanne D. reported acquisition or exercise transactions in this Form 4 filing.
Pennant Group director Suzanne D. Snapper received an equity grant of 1,900 shares of Common Stock as compensation. The award was reported at a price of $0.00 per share and increases her direct holdings to 228,464 shares. These shares vest in three annual installments beginning April 15, 2027.
Walbom Lynette reported acquisition or exercise transactions in this Form 4 filing.
Pennant Group, Inc. Chief Financial Officer Lynette Walbom reported receiving equity awards. On March 3, 2026, she was granted 8,025 shares of common stock at no cost, which vest immediately on that date, bringing her direct common stock holdings to 10,688 shares. On March 5, 2026, she was also granted 34,000 stock options to buy common stock at $33.30 per share, vesting in five equal annual installments beginning March 5, 2027 and expiring March 5, 2036. The amendment corrects the amount of securities beneficially owned as of the reported transaction dates.
The Pennant Group, Inc. is asking stockholders to vote at its 2026 annual meeting on electing three Class I directors, ratifying Deloitte & Touche LLP as auditor, and approving executive pay on an advisory basis. The meeting is on May 14, 2026 in Holladay, Utah.
Stockholders of record as of March 17, 2026, holding a total of 34,953,297 common shares, are entitled to one vote per share. The Board recommends voting FOR all three proposals and emphasizes performance-based executive compensation, extensive stockholder engagement, and a largely independent, committee-driven board structure.
The Vanguard Group amended its Schedule 13G for Pennant Group Inc/The to report 0 shares beneficially owned (representing 0% of the class). The filing explains that on January 12, 2026 Vanguard implemented an internal realignment and began reporting certain subsidiaries and business divisions separately; as a result, Vanguard states it no longer has beneficial ownership over securities held by those entities. The amendment is signed by Ashley Grim on March 27, 2026.
Pennant Group, Inc. executive Kirk Sterling Cheney, EVP, General Counsel and Corporate Secretary, reported equity compensation awards. He received 4,085 shares of common stock at no cost, which vest immediately on March 3, 2026, bringing his direct holdings to 21,005 shares.
He was also granted a stock option for 30,000 shares of common stock at an exercise price of $33.30 per share. This option begins vesting in five equal annual installments starting on March 5, 2027 and expires on March 5, 2036, representing a long-term incentive award.
Pennant Group Chief Operating Officer John J. Gochnour received new equity awards. On March 3, 2026, he acquired 18,565 shares of common stock as a grant at no cost, bringing his direct common stock holdings to 152,815 shares. On March 5, 2026, he was granted options to buy 41,000 shares of common stock at $33.30 per share, exercisable until March 5, 2036. The 18,565-share grant vests immediately on March 3, 2026, while the 41,000 stock options vest in five equal annual installments beginning March 5, 2027.